Literature DB >> 30126300

Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren's Syndrome.

Srikanth R Janga1, Mihir Shah1, Yaping Ju2, Zhen Meng2, Maria C Edman1, Sarah F Hamm-Alvarez1,2.   

Abstract

CONTEXT: Cathepsin S (CTSS) activity is elevated in Sjögren's Syndrome (SS) patient tears.
OBJECTIVE: To evaluate longitudinal expression of tear and tissue CTSS activity relative to other disease indicators in Non-Obese Diabetic (NOD) mice.
METHODS: CTSS activity was measured in tears and lacrimal glands (LG) from male 1-6 month (M) NOD and 1 and 6 M BALB/c mice. Lymphocytic infiltration was quantified by histopathology, while disease-related proteins (Rab3D, CTSS, collagen 1) were quantified using q-PCR and immunofluorescence.
RESULTS: In NOD LG, lymphocytic infiltration was noted by 2 M and established by 3 M (p < 0.01). IFN-ɣ, TNF-α, and MHC II expression were increased by 2 M (p < 0.01). Tear CTSS activity was significantly elevated at 2 M (p < 0.001) to a maximum of 10.1-fold by 6 M (p < 0.001). CTSS activity in LG lysates was significantly elevated by 2 M (p < 0.001) to a maximum of 14-fold by 3 M (p < 0.001). CTSS and Rab3D immunofluorescence were significantly increased and decreased maximally in LG acini by 3 M and 2 M, respectively. Comparable changes were not detected between 1 and 6 M BALB/c mouse LG, although Collagen 1 was decreased by 6 M in LG of both strains.
CONCLUSION: Tear CTSS activity is elevated with other early disease indicators, suggesting potential as an early stage biomarker for SS.

Entities:  

Keywords:  Cathepsin S; Sjögren’s Syndrome; autoimmune inflammation; dacryoadenitis; lacrimal gland; non-obese diabetic mouse

Mesh:

Substances:

Year:  2018        PMID: 30126300      PMCID: PMC6414277          DOI: 10.1080/1354750X.2018.1514656

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  9 in total

1.  Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.

Authors:  Changrim Lee; Hao Guo; Wannita Klinngam; Srikanth R Janga; Frances Yarber; Santosh Peddi; Maria C Edman; Nishant Tiwari; Siyu Liu; Stan G Louie; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  Mol Pharm       Date:  2019-05-30       Impact factor: 4.939

2.  Differential effects of specific cathepsin S inhibition in biocompartments from patients with primary Sjögren syndrome.

Authors:  Patrick Hargreaves; Douglas Daoudlarian; Michel Theron; Fabrice A Kolb; Marianne Manchester Young; Bernhard Reis; Andre Tiaden; Bettina Bannert; Diego Kyburz; Tobias Manigold
Journal:  Arthritis Res Ther       Date:  2019-07-18       Impact factor: 5.156

3.  Cathepsin S is a novel target for age-related dry eye.

Authors:  Zhiyuan Yu; Jinmiao Li; Gowthaman Govindarajan; Sarah F Hamm-Alvarez; Jehan Alam; De-Quan Li; Cintia S de Paiva
Journal:  Exp Eye Res       Date:  2021-12-12       Impact factor: 3.467

4.  Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.

Authors:  Runzhong Fu; Srikanth Janga; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2021-09-03       Impact factor: 3.770

5.  Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.

Authors:  Yaping Ju; Maria C Edman; Hao Guo; Srikanth Reddy Janga; Santosh Peddi; Stan G Louie; Jason A Junge; J Andrew MacKay; Sarah F Hamm-Alvarez
Journal:  Biomacromolecules       Date:  2020-12-27       Impact factor: 6.988

6.  Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren's Syndrome.

Authors:  Wannita Klinngam; Srikanth R Janga; Changrim Lee; Yaping Ju; Frances Yarber; Mihir Shah; Hao Guo; Dandan Wang; J Andrew MacKay; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Sci Rep       Date:  2019-07-02       Impact factor: 4.379

7.  Correlation of cathepsin S with coronary stenosis degree, carotid thickness, blood pressure, glucose and lipid metabolism and vascular endothelial function in atherosclerosis.

Authors:  Shengyang Huang; Yu Cao
Journal:  Exp Ther Med       Date:  2019-11-19       Impact factor: 2.447

8.  Rab27a Contributes to Cathepsin S Secretion in Lacrimal Gland Acinar Cells.

Authors:  Runzhong Fu; Maria C Edman; Sarah F Hamm-Alvarez
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

9.  Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.

Authors:  Shruti Singh Kakan; Maria C Edman; Alexander Yao; Curtis T Okamoto; Annie Nguyen; Brooke E Hjelm; Sarah F Hamm-Alvarez
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.